Oragenics (OGEN) Financials

$7.2 M

Mkt cap, 21-May-2018
Net income (Q1, 2018)-2.1 M
Cash, 31-Mar-20184.8 M

Revenue/Financials

Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1 m939.9 k1.2 m

Revenue growth, %

(9%)25%(100%)

Cost of goods sold

343.4 k369.6 k481.7 k

Gross profit

688.9 k570.3 k694.1 k

Gross profit Margin, %

67%61%59%

R&D expense

4.8 m

General and administrative expense

3.8 m

Operating expense total

8.5 m

EBIT

(16.2 m)(5.8 m)(11.7 m)

EBIT margin, %

(1570%)(619%)(991%)

Interest expense

17.5 k4 k76.7 k4.1 k

Interest income

23.5 k37 k21.4 k40.1 k

Pre tax profit

(16.1 m)(5.8 m)(11.7 m)(8.5 m)

Income tax expense

Net Income

(16.1 m)(5.8 m)(11.7 m)(7 m)

Quarterly

USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Revenue

242 k329.8 k262.3 k

Cost of goods sold

86.8 k134.6 k90 k

Gross profit

155.3 k195.2 k172.3 k

Gross profit Margin, %

64%59%66%

R&D expense

5.6 m1.2 m1.2 m812.6 k924.8 k1.1 m1.3 m

General and administrative expense

873.6 k853.9 k994.4 k920.7 k1.1 m865.2 k795.5 k

Operating expense total

6.5 m2 m2.2 m1.7 m2 m2 m(2.1 m)

EBIT

(6.3 m)(1.8 m)(2.1 m)

EBIT margin, %

(2615%)(555%)(787%)

Interest expense

10 k39.6 k771 885 1.3 k801 837

Interest income

5.8 k5 k2.6 k1.4 k18.5 k1.9 k3.5 k

Pre tax profit

(6.3 m)(1.9 m)(2.1 m)(1.7 m)(2 m)(2 m)(2.1 m)

Income tax expense

Net Income

(7.6 m)(9.5 m)(2.1 m)(2.4 m)(4.3 m)(2 m)(2.1 m)

Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

16.3 m10.4 m5.1 m4.1 m

Accounts Receivable

24.1 m

Inventories

175.2 k119.4 k211.7 k141.1 k

Current Assets

16.8 m11 m5.6 m4.2 m

PP&E

26.9 k109.3 k140.7 k87.5 k

Total Assets

16.8 m11.1 m5.8 m4.3 m

Accounts Payable

910 k710.2 k969.8 k1.3 m

Current Liabilities

992.8 k796.3 k1 m1.3 m

Additional Paid-in Capital

86 m86.2 m92.3 m97.6 m

Retained Earnings

(70.2 m)(75.9 m)(87.7 m)(94.7 m)

Total Equity

15.8 m10.3 m4.7 m3 m

Financial Leverage

1.1 x1.1 x1.2 x1.5 x

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Cash

12.9 m11.8 m9.1 m8 m6.7 m3.4 m5.5 m5.1 m2.2 m4.8 m

Accounts Receivable

22.8 k26.3 k

Inventories

239 k263.9 k377 k364.1 k299.3 k241.5 k

Current Assets

13.3 m12.3 m9.6 m8.5 m7.2 m3.8 m6 m5.3 m2.3 m5.5 m

PP&E

31.9 k26.3 k167.7 k170.7 k159.3 k122.4 k104.2 k107.1 k69.4 k14 k

Total Assets

13.3 m12.3 m9.8 m8.7 m7.4 m4 m6.1 m5.4 m2.4 m5.5 m

Accounts Payable

703.2 k604.4 k509.3 k548.7 k761.8 k986.7 k693.5 k786.2 k1.1 m1.1 m

Current Liabilities

777.9 k739.5 k606 k5.6 m5.9 m1.1 m897.8 k909.3 k1.2 m1.2 m

Additional Paid-in Capital

86.2 m86.2 m86.4 m86.6 m86.9 m92.6 m97.2 m97.4 m97.8 m101.8 m

Retained Earnings

(73.7 m)(74.7 m)(77.2 m)(83.6 m)(85.4 m)(89.7 m)(90 m)(92 m)(96.7 m)(103.6 m)

Total Equity

12.6 m11.6 m9.2 m3.1 m1.5 m2.9 m5.2 m4.5 m1.2 m4.3 m

Financial Leverage

1.1 x1.1 x1.1 x2.8 x4.9 x1.4 x1.2 x1.2 x2 x1.3 x

Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(16.1 m)(5.8 m)(11.7 m)(7 m)

Depreciation and Amortization

76.5 k27.7 k71.2 k75 k

Accounts Receivable

5.4 k48.8 k

Inventories

203.6 k214.8 k66.1 k229.3 k

Accounts Payable

(234.5 k)(199.7 k)331.1 k446 k

Cash From Operating Activities

(6.8 m)(5.6 m)(5.1 m)(7.1 m)

Purchases of PP&E

(18.8 k)(110.7 k)(102.5 k)(27.2 k)

Cash From Investing Activities

(18.8 k)(110.2 k)(101.2 k)

Cash From Financing Activities

13.1 m(160 k)

Interest Paid

3.1 k4.1 k5.2 k4.1 k

Quarterly

USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(7.6 m)(9.5 m)(2.1 m)(2.4 m)(4.3 m)(2 m)(2.1 m)

Depreciation and Amortization

32.5 k52.5 k18.3 k36.5 k55.4 k18 k7.7 k

Accounts Receivable

(11.2 k)(3.8 k)(11.6 k)

Accounts Payable

(161.5 k)51.6 k17 k(137.5 k)(44.9 k)(174.6 k)293.4 k

Cash From Operating Activities

(2.2 m)(3.5 m)(1.7 m)(3.5 m)(5.1 m)(1.9 m)(1.4 m)

Purchases of PP&E

(93.9 k)(102.5 k)(72.2 k)(93.9 k)(27.2 k)

Cash From Investing Activities

(93.9 k)(101.2 k)(72.2 k)

Cash From Financing Activities

(79.5 k)(113.8 k)(33.9 k)(5 k)(41.6 k)

Interest Paid

1.5 k1.2 k771 885 2.8 k801 4.5 k

Ratios

USDY, 2018

Financial Leverage

1.3 x
Report incorrect company information